Search Page

1

Cite

Share

Data Resource Profile: Clinical Practice Research Datalink (CPRD).

Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L. Herrett E, et al. Among authors: van staa t. Int J Epidemiol. 2015 Jun;44(3):827-36. doi: 10.1093/ije/dyv098. Epub 2015 Jun 6. Int J Epidemiol. 2015. PMID: 26050254 Free PMC article.

Cite

Share

2

Cite

Share

The use of wearable technology to monitor physical activity in patients with COPD: a literature review.

Pericleous P, van Staa TP. Pericleous P, et al. Among authors: van staa tp. Int J Chron Obstruct Pulmon Dis. 2019 Jun 19;14:1317-1322. doi: 10.2147/COPD.S193037. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31354259 Free PMC article. Review.

Cite

Share

3

Cite

Share

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.

van Staa TP, Leufkens HG, Cooper C. van Staa TP, et al. Osteoporos Int. 2002 Oct;13(10):777-87. doi: 10.1007/s001980200108. Osteoporos Int. 2002. PMID: 12378366 Review.

Cite

Share

4

Cite

Share

Use of oral corticosteroids and risk of fractures.

Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Van Staa TP, et al. J Bone Miner Res. 2000 Jun;15(6):993-1000. doi: 10.1359/jbmr.2000.15.6.993. J Bone Miner Res. 2000. PMID: 10841167 Free article. Review.

Cite

Share

5

Cite

Share

Epidemiology of fractures in England and Wales.

van Staa TP, Dennison EM, Leufkens HG, Cooper C. van Staa TP, et al. Bone. 2001 Dec;29(6):517-22. doi: 10.1016/s8756-3282(01)00614-7. Bone. 2001. PMID: 11728921

Cite

Share

6

Cite

Share

Excess mortality following hip fracture: a systematic epidemiological review.

Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Abrahamsen B, et al. Among authors: van staa t. Osteoporos Int. 2009 Oct;20(10):1633-50. doi: 10.1007/s00198-009-0920-3. Epub 2009 May 7. Osteoporos Int. 2009. PMID: 19421703 Review.

Cite

Share

7

Cite

Share

Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar.

Li Y, Sperrin M, Ashcroft DM, van Staa TP. Li Y, et al. Among authors: van staa tp. BMJ. 2020 Nov 4;371:m3919. doi: 10.1136/bmj.m3919. BMJ. 2020. PMID: 33148619 Free PMC article.

Cite

Share

8

Cite

Share

Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study.

Abtahi S, Driessen JHM, Burden AM, Souverein PC, van den Bergh JP, van Staa TP, Boonen A, de Vries F. Abtahi S, et al. Among authors: van staa tp. Ann Rheum Dis. 2020 Dec 11:annrheumdis-2020-218758. doi: 10.1136/annrheumdis-2020-218758. Online ahead of print. Ann Rheum Dis. 2020. PMID: 33310727

Cite

Share

9

Cite

Share

Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status.

Curtis EM, van der Velde R, Moon RJ, van den Bergh JP, Geusens P, de Vries F, van Staa TP, Cooper C, Harvey NC. Curtis EM, et al. Among authors: van staa tp. Bone. 2016 Jun;87:19-26. doi: 10.1016/j.bone.2016.03.006. Epub 2016 Mar 9. Bone. 2016. PMID: 26968752 Free PMC article.

Cite

Share

10

Cite

Share

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N. Kanis JA, et al. Among authors: van staa t. Osteoporos Int. 2007 Aug;18(8):1033-46. doi: 10.1007/s00198-007-0343-y. Epub 2007 Feb 24. Osteoporos Int. 2007. PMID: 17323110 Review.

Cite

Share